{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:54:16Z","timestamp":1760316856334,"version":"build-2065373602"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.schres.2021.06.012","type":"journal-article","created":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T23:56:59Z","timestamp":1625183819000},"page":"24-30","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Toxoplasma gondii, Herpesviridae and long-term risk of transition to first-episode psychosis in an ultra high-risk sample"],"prefix":"10.1016","volume":"233","author":[{"given":"E.","family":"Burkhardt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Berger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.H.","family":"Yolken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.P.","family":"Yuen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.J.","family":"Wood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.M.","family":"Francey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.D.","family":"McGorry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.R.","family":"Yung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.P.","family":"Amminger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2021.06.012_bb0005","doi-asserted-by":"crossref","DOI":"10.1007\/s11920-019-1027-y","article-title":"Predictors of transition to psychosis in individuals at clinical high risk","volume":"21","author":"Addington","year":"2019","journal-title":"Curr. Psychiatry Rep."},{"year":"2000","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","key":"10.1016\/j.schres.2021.06.012_bb0010"},{"key":"10.1016\/j.schres.2021.06.012_bb0015","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.biopsych.2006.09.034","article-title":"Antibodies to infectious agents in individuals at ultra-high risk for psychosis","volume":"61","author":"Amminger","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.schres.2021.06.012_bb0020","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1001\/archpsyc.1982.04290070020005","article-title":"Negative symptoms in schizophrenia: definition and reliability","volume":"39","author":"Andreasen","year":"1982","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2021.06.012_bb0025","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.schres.2011.10.026","article-title":"Infectious agents associated with schizophrenia: a meta-analysis","volume":"136","author":"Arias","year":"2012","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2021.06.012_bb0030","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1001\/archpsyc.58.11.1032","article-title":"Maternal infections and subsequent psychosis among offspring","volume":"58","author":"Buka","year":"2001","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2021.06.012_bb0035","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1093\/schbul\/sbm008","article-title":"Effects of Toxoplasma gondii infection on the brain","volume":"33","author":"Carruthers","year":"2007","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2021.06.012_bb0040","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1136\/sti.2005.016899","article-title":"Prevalence of infection with herpes simplex virus types 1 and 2 in Australia: a nationwide population based survey","volume":"82","author":"Cunningham","year":"2006","journal-title":"Sex. Transm. Infect."},{"key":"10.1016\/j.schres.2021.06.012_bb0045","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s11011-016-9822-1","article-title":"The known and missing links between Toxoplasma gondii and schizophrenia","volume":"31","author":"Elsheikha","year":"2016","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.schres.2021.06.012_bb0050","doi-asserted-by":"crossref","first-page":"105","DOI":"10.14411\/fp.2010.013","article-title":"Toxoplasmosis as a cause for behaviour disorders-overview of evidence and mechanisms","volume":"57","author":"Fekadu","year":"2010","journal-title":"Folia Parasitol. (Praha)"},{"key":"10.1016\/j.schres.2021.06.012_bb0055","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.schres.2018.05.007","article-title":"Latent toxoplasma infection in real-world schizophrenia: results from the national FACE-SZ cohort","volume":"201","author":"Fond","year":"2018","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2021.06.012_bb0060","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.jad.2018.11.004","article-title":"Inflammatory DEpression Advances in Schizophrenia (IDEAS): a precision medicine approach of the national FACE-SZ cohort","volume":"245","author":"Fond","year":"2019","journal-title":"J. Affect. Disord."},{"issue":"7","key":"10.1016\/j.schres.2021.06.012_bb0065","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1001\/jamapsychiatry.2019.4779","article-title":"Prevention of psychosis: advances in detection, prognosis, and intervention","volume":"77","author":"Fusar-Poli","year":"2020","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.schres.2021.06.012_bb0070","doi-asserted-by":"crossref","first-page":"22766","DOI":"10.3402\/jom.v5i0.22766","article-title":"Herpesviruses: latency and reactivation\u2013viral strategies and host response","volume":"5","author":"Grinde","year":"2013","journal-title":"J. Oral Microbiol."},{"key":"10.1016\/j.schres.2021.06.012_bb0075","doi-asserted-by":"crossref","first-page":"843","DOI":"10.2147\/NDT.S79285","article-title":"Different presence of Chlamydia pneumoniae, herpes simplex virus type 1, human herpes virus 6, and Toxoplasma gondii in schizophrenia: meta-analysis and analytical study","volume":"11","author":"Guti\u00e9rrez-Fern\u00e1ndez","year":"2015","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.schres.2021.06.012_bb0080","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.4088\/JCP.15m10133","article-title":"Effects of cumulative Herpesviridae and Toxoplasma gondii infections on cognitive function in healthy, bipolar, and schizophrenia subjects","volume":"78","author":"Hamdani","year":"2017","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2021.06.012_bb0085","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","article-title":"The assessment of anxiety states by rating","volume":"32","author":"Hamilton","year":"1959","journal-title":"Br. J. Med. Psychol."},{"key":"10.1016\/j.schres.2021.06.012_bb0090","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.schres.2021.06.012_bb0095","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/acps.12031","article-title":"Differences in onset of disease and severity of psychopathology between toxoplasmosis-related and toxoplasmosis-unrelated schizophrenia","volume":"127","author":"Holub","year":"2013","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.schres.2021.06.012_bb0100","doi-asserted-by":"crossref","DOI":"10.1017\/S0950268818002947","article-title":"Human toxoplasmosis: a systematic review for genetic diversity of toxoplasma gondii in clinical samples","volume":"147","author":"Hosseini","year":"2019","journal-title":"Epidemiol. Infect."},{"key":"10.1016\/j.schres.2021.06.012_bb0105","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/aje\/154.4.357","article-title":"Toxoplasma gondii infection in the United States: seroprevalence and risk factors","volume":"154","author":"Jones","year":"2001","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.schres.2021.06.012_bb0110","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2017.162","article-title":"Pathogen-mediated NMDA receptor autoimmunity and cellular barrier dysfunction in schizophrenia","volume":"7","author":"Kannan","year":"2017","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.schres.2021.06.012_bb0115","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1479-828X.2001.tb01289.x","article-title":"Seroprevalence of varicella zoster virus, parvovirus B19 and Toxoplasma gondii in a Melbourne obstetric population: implications for management","volume":"41","author":"Karunajeewa","year":"2001","journal-title":"Aust. N. Z. J. Obstet. Gynaecol."},{"key":"10.1016\/j.schres.2021.06.012_bb0120","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/YCO.0b013e32816ebc8c","article-title":"Age of onset of mental disorders: a review of recent literature","volume":"20","author":"Kessler","year":"2007","journal-title":"Curr. Opin. Psychiatry"},{"key":"10.1016\/j.schres.2021.06.012_bb0125","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.schres.2012.05.023","article-title":"Childhood infection and adult schizophrenia: a meta-analysis of population-based studies","volume":"139","author":"Khandaker","year":"2012","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2021.06.012_bb0130","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1017\/S0033291712000736","article-title":"Prenatal maternal infection, neurodevelopment and adult schizophrenia: a systematic review of population-based studies","volume":"43","author":"Khandaker","year":"2013","journal-title":"Psychol. Med."},{"key":"10.1016\/j.schres.2021.06.012_bb0135","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.mehy.2009.09.040","article-title":"A unifying hypothesis of schizophrenia: abnormal immune system development may help explain roles of prenatal hazards, post-pubertal onset, stress, genes, climate, infections, and brain dysfunction","volume":"74","author":"Kinney","year":"2010","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.schres.2021.06.012_bb0140","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.amjmed.2004.08.023","article-title":"Toxoplasmosis in pregnancy","volume":"118","author":"Kravetz","year":"2005","journal-title":"Am. J. Med."},{"key":"10.1016\/j.schres.2021.06.012_bb0145","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.schres.2013.10.004","article-title":"Association between antibodies to multiple infectious and food antigens and new onset schizophrenia among US military personnel","volume":"151","author":"Li","year":"2013","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2021.06.012_bb0150","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2017.00037","article-title":"From toxoplasmosis to schizophrenia via NMDA dysfunction: peptide overlap between toxoplasma gondii and N-methyl\u2011d-aspartate receptors as a potential mechanistic link","volume":"8","author":"Lucchese","year":"2017","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.schres.2021.06.012_bb0155","first-page":"158","article-title":"Central nervous system infections in individuals with HIV-1 infection","volume":"8","author":"Mamidi","year":"2002","journal-title":"J. Neuro-Oncol."},{"issue":"Suppl. 1","key":"10.1016\/j.schres.2021.06.012_bb0160","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1093\/jpids\/piu077","article-title":"Congenital toxoplasmosis","volume":"3","author":"McAuley","year":"2014","journal-title":"J. Pediatr. Infect. Dis. Soc."},{"key":"10.1016\/j.schres.2021.06.012_bb0165","series-title":"Risk Factors for Psychosis","first-page":"1","article-title":"Historical perspectives on psychosis risk","author":"Mei","year":"2020"},{"key":"10.1016\/j.schres.2021.06.012_bb0170","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/3142918","article-title":"First age-and gender-matched case-control study in Australia examining the possible association between Toxoplasma gondii infection and type 2 diabetes mellitus: the Busselton health study","volume":"2020","author":"Molan","year":"2020","journal-title":"J. Parasitol. Res."},{"key":"10.1016\/j.schres.2021.06.012_bb0175","series-title":"Conns Current Therapy","first-page":"3355","article-title":"Toxoplasma gondii","author":"Montoya","year":"2003"},{"key":"10.1016\/j.schres.2021.06.012_bb0180","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/schbul\/sbm009","article-title":"Early infections of Toxoplasma gondii and the later development of schizophrenia","volume":"33","author":"Mortensen","year":"2007","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2021.06.012_bb0185","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.chc.2019.08.001","article-title":"The prodrome of psychotic disorders: identification, prediction, and preventive treatment","volume":"29","author":"Nelson","year":"2020","journal-title":"Child Adolesc. Psychiatr. Clin."},{"key":"10.1016\/j.schres.2021.06.012_bb0190","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1001\/jamapsychiatry.2013.1270","article-title":"Long-term follow-up of a group at ultra high risk (\u201cprodromal\u201d) for psychosis: the PACE 400 study","volume":"70","author":"Nelson","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.schres.2021.06.012_bb0195","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1176\/appi.ajp.2007.06081254","article-title":"Selected infectious agents and risk of schizophrenia among US military personnel","volume":"165","author":"Niebuhr","year":"2008","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2021.06.012_bb0200","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.schres.2011.08.006","article-title":"Toxoplasma gondii antibody titers and history of suicide attempts in patients with schizophrenia","volume":"133","author":"Okusaga","year":"2011","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2021.06.012_bb0205","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/schbul\/sbz039","article-title":"What causes the onset of psychosis in individuals at clinical high risk? A meta-analysis of risk and protective factors","volume":"46","author":"Oliver","year":"2019","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2021.06.012_bb0210","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The brief psychiatric rating scale","volume":"10","author":"Overall","year":"1962","journal-title":"Psychol. Rep."},{"key":"10.1016\/j.schres.2021.06.012_bb0215","first-page":"258","article-title":"Toxoplasma gondii exposure affects neural processing speed as measured by acoustic startle latency in schizophrenia and controls","volume":"150","author":"Pearce","year":"2013","journal-title":"DSM-5"},{"key":"10.1016\/j.schres.2021.06.012_bb0220","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1176\/appi.ajp.2011.10091351","article-title":"Toxoplasma infection and later development of schizophrenia in mothers","volume":"168","author":"Pedersen","year":"2011","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2021.06.012_bb0225","doi-asserted-by":"crossref","first-page":"5133","DOI":"10.1128\/JCM.42.11.5133-5138.2004","article-title":"Evaluation of a candidate international standard preparation for human anti-Toxoplasma immunoglobulin G","volume":"42","author":"Rigsby","year":"2004","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.schres.2021.06.012_bb0230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007807","article-title":"Acute Toxoplasma infection in pregnant women worldwide: a systematic review and meta-analysis","volume":"13","author":"Rostami","year":"2019","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.schres.2021.06.012_bb0235","first-page":"425","article-title":"Serological detection of type-specific IgG to herpes simplex virus by novel ELISAs based on recombinant and highly purified glycoprotein G","volume":"50","author":"Sauerbrei","year":"2004","journal-title":"Clin. Lab."},{"key":"10.1016\/j.schres.2021.06.012_bb0240","first-page":"375","article-title":"Improving prognostic accuracy in subjects at clinical high risk for psychosis: systematic review of predictive models and meta-analytical sequential testing simulation","volume":"43","author":"Schmidt","year":"2016","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2021.06.012_bb0245","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1128\/CVI.00203-06","article-title":"National serosurvey of cytomegalovirus in Australia","volume":"13","author":"Seale","year":"2006","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.schres.2021.06.012_bb0250","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.schres.2008.07.017","article-title":"Antibodies to cytomegalovirus and Herpes Simplex Virus 1 associated with cognitive function in schizophrenia","volume":"106","author":"Shirts","year":"2008","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2021.06.012_bb0255","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S1474-4422(07)70267-3","article-title":"The neurotropic herpes viruses: herpes simplex and varicella-zoster","volume":"6","author":"Steiner","year":"2007","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.schres.2021.06.012_bb0260","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0148435","article-title":"Is Toxoplasma gondii infection related to brain and behavior impairments in humans? Evidence from a population-representative birth cohort","volume":"11","author":"Sugden","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.schres.2021.06.012_bb0320","doi-asserted-by":"crossref","first-page":"104441","DOI":"10.1016\/j.micpath.2020.104441","article-title":"Protective immunity induced by a DNA vaccine cocktail expressing TgSAG1, TgROP2, and the genetic adjuvant HBsAg against Toxoplasma gondii infection","volume":"147","author":"Sun","year":"2020","journal-title":"Microbial Pathogenesis"},{"key":"10.1016\/j.schres.2021.06.012_bb0265","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/acps.12423","article-title":"Beyond the association. Toxoplasma gondii in schizophrenia, bipolar disorder, and addiction: systematic review and meta-analysis","volume":"132","author":"Sutterland","year":"2015","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.schres.2021.06.012_bb0270","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/S0020-7519(00)00124-7","article-title":"Toxoplasma gondii: from animals to humans","volume":"30","author":"Tenter","year":"2000","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.schres.2021.06.012_bb0275","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.schres.2014.09.027","article-title":"The urban risk and migration risk factors for schizophrenia: are cats the answer?","volume":"159","author":"Torrey","year":"2014","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2021.06.012_bb0280","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1093\/schbul\/sbs043","article-title":"Toxoplasma gondii and other risk factors for schizophrenia: an update","volume":"38","author":"Torrey","year":"2012","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2021.06.012_bb0285","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.schres.2019.01.001","article-title":"Assessment of cognitive impairment in HSV-1 positive schizophrenia and bipolar patients: systematic review and meta-analysis","volume":"209","author":"Tucker","year":"2019","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2021.06.012_bb0290","doi-asserted-by":"crossref","DOI":"10.1038\/srep22551","article-title":"Prevalence, incidence estimations, and risk factors of Toxoplasma gondii infection in Germany: a representative, cross-sectional, serological study","volume":"6","author":"Wilking","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.schres.2021.06.012_bb0295","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1086\/319221","article-title":"Antibodies to Toxoplasma gondii in individuals with first-episode schizophrenia","volume":"32","author":"Yolken","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.schres.2021.06.012_bb0300","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006040","article-title":"Evidence of increased exposure to Toxoplasma gondii in individuals with recent onset psychosis but not with established schizophrenia","volume":"11","author":"Yolken","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.schres.2021.06.012_bb0305","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0920-9964(02)00167-6","article-title":"Psychosis prediction: 12-month follow up of a high-risk (\u201cprodromal\u201d) group","volume":"60","author":"Yung","year":"2003","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2021.06.012_bb0310","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0920-9964(03)00192-0","article-title":"Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features","volume":"67","author":"Yung","year":"2004","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2021.06.012_bb0315","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1080\/j.1440-1614.2005.01714.x","article-title":"Mapping the onset of psychosis: the comprehensive assessment of at-risk mental states","volume":"39","author":"Yung","year":"2005","journal-title":"Aust. N. Z. J. Psychiatry"}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996421002243?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996421002243?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:41:25Z","timestamp":1760298085000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996421002243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":64,"alternative-id":["S0920996421002243"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2021.06.012","relation":{},"ISSN":["0920-9964"],"issn-type":[{"type":"print","value":"0920-9964"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Toxoplasma gondii, Herpesviridae and long-term risk of transition to first-episode psychosis in an ultra high-risk sample","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2021.06.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}